“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: PP73 Loss of transfer RNA U34 modifying enzymes impairs hematopoietic stem and progenitor cell differentiation and function

€3.03

SKU: product-article-16336 Category: General

Description

Description

PP73 Loss of transfer RNA U34 modifying enzymes impairs hematopoietic stem and progenitor cell differentiation and function

Top

Article: PP73 Loss of transfer RNA U34 modifying enzymes impairs hematopoietic stem and progenitor cell differentiation and function

Description

Related products

Article: Highlights in gynaecological cancers

Article: Highlights in gynaecological cancers

Article: Highlights in melanoma

Article: Highlights in breast cancer